Takeover has gone very very quiet. And I'm not complaining...the 'offer' if true...was much too low. This is a good hold for 2013. A buy for non-holders in my opinion.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
